Sutro Biopharma Overview

  • Founded
  • 2003
Founded
  • Status
  • Public
  • Employees
  • 177
Employees
  • Stock Symbol
  • STRO
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $7.97
  • (As of Thursday Closing)

Sutro Biopharma General Information

Description

Sutro Biopharma Inc is a clinical stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.

Contact Information

Formerly Known As
Fundamental Applied Biology
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Biotechnology
Stock Exchange
NAS
Primary Office
  • 310 Utah Avenue
  • Suite 150
  • South San Francisco, CA 94080
  • United States
+1 (650) 000-0000

Sutro Biopharma Timeline

2017201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Sutro Biopharma Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$7.97 $8.03 $6.00 - $12.75 $286M 35.9M 164K -$2.64

Sutro Biopharma Financials Summary

In Thousands,
USD
TTM 30-Jun-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 187,179 140,172 285,069
Revenue 40,203 42,736 38,419 51,741
EBITDA (13,998) (55,041) (32,394) (14,971)
Net Income (17,424) (55,744) (35,317) (19,688)
Total Assets 277,538 156,370 223,139 40,769
Total Debt 24,281 9,876 14,724 14,563
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Sutro Biopharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Sutro Biopharma‘s full profile, request access.

Request a free trial

Sutro Biopharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Sutro Biopharma‘s full profile, request access.

Request a free trial

Sutro Biopharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Sutro Biopharma Inc is a clinical stage drug discovery, development, and manufacturing company. It is mainly engaged in
Drug Delivery
South San Francisco, CA
177 As of 2020
00000
000000 - 000 00000

000000 0

ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore e
0000000000000
South San Francisco, CA
000 As of 0000
00000
000000 - 000 00000

0000 000

reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaec
0000000000000
Cambridge, MA
00 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sutro Biopharma Competitors (54)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CytomX Therapeutics Formerly VC-backed South San Francisco, CA 000 00000 000000 - 000 00000
0000 000000000000 Formerly VC-backed Cambridge, MA 00 00000 000000000 00000
000000000000 Venture Capital-Backed Seattle, WA 00 000.00 00000000000 000.00
0000 00000000000 Formerly VC-backed Redwood City, CA 00 00000 000000&0 00000
000000 00000000000 Corporation PA 000 000.00 00000000 000.00
You’re viewing 5 of 54 competitors. Get the full list »

Sutro Biopharma Executive Team (25)

Name Title Board Seat Contact Info
William Newell JD Chief Executive Officer & Board Member
Edward Albini Chief Financial Officer
Trevor Hallam Ph.D Chief Scientific Officer
James Swartz Founder, Director and Scientific Advisory Board Member
Toni Kline Ph.D Director of Chemistry
You’re viewing 5 of 25 executive team members. Get the full list »

Sutro Biopharma Board Members (19)

Name Representing Role Since
Connie Matsui Sutro Biopharma Chairman & Board Member 000 0000
Daniel Petree JD Self Board Member 000 0000
James Panek Sutro Biopharma Board Member 000 0000
John Freund MD Skyline Ventures Board Member 000 0000
Joseph Lobacki Sutro Biopharma Board Member 000 0000
You’re viewing 5 of 19 board members. Get the full list »

Sutro Biopharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sutro Biopharma Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Sutro Biopharma‘s full profile, request access.

Request a free trial

Sutro Biopharma Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 08-Jan-2014 0000 00000 000 Drug Discovery 0000000 000000 00
To view Sutro Biopharma’s complete investments history, request access »

Sutro Biopharma Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000 08-Jan-2014 0000 00000 000 Completed
  • 2 buyers
To view Sutro Biopharma’s complete exits history, request access »